84 related articles for article (PubMed ID: 26402882)
21. Proteomic biomarkers in diabetic nephropathy--reality or future promise?
Mischak H; Rossing P
Nephrol Dial Transplant; 2010 Sep; 25(9):2843-5. PubMed ID: 20571095
[No Abstract] [Full Text] [Related]
22. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
Ratzmann KP; Raskovic M; Schimke E
Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
[TBL] [Abstract][Full Text] [Related]
23. [Qualitative study of proteinuria in diabetic nephropathy].
Faure Nogueras E; Blasco Comenge MC; Guillén Martínez G
An Med Interna; 1991 Jul; 8(7):333-5. PubMed ID: 1932490
[TBL] [Abstract][Full Text] [Related]
24. [The renal tubulointerstitium in diabetes mellitus].
Ueno M; Nishi S; Arakawa M
Nihon Rinsho; 1995 Aug; 53(8):1981-7. PubMed ID: 7563638
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of the detection of microquantitative urinary protein in diabetics].
Wang SP; Tang GP; Qiu HX
Zhonghua Nei Ke Za Zhi; 1988 Jul; 27(7):423-6, 454-5. PubMed ID: 3219948
[No Abstract] [Full Text] [Related]
26. Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis.
Zheng S; Powell DW; Zheng F; Kantharidis P; Gnudi L
J Diabetes Res; 2016; 2016():5241549. PubMed ID: 26881250
[No Abstract] [Full Text] [Related]
27. Tubular biomarkers to assess progression of diabetic nephropathy.
Tramonti G; Kanwar YS
Kidney Int; 2011 May; 79(10):1042-4. PubMed ID: 21527942
[TBL] [Abstract][Full Text] [Related]
28. Lysozymuria in diabetes.
Farr M; Wardle EN; Wilkinson K
Br Med J; 1976 Mar; 1(6010):624-5. PubMed ID: 1252852
[TBL] [Abstract][Full Text] [Related]
29. Gliquidone decreases urinary protein by promoting tubular reabsorption in diabetic Goto-Kakizaki rats.
Ke JT; Li M; Xu SQ; Zhang WJ; Jiang YW; Cheng LY; Chen L; Lou JN; Wu W
J Endocrinol; 2014 Feb; 220(2):129-41. PubMed ID: 24254365
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.
Bolignano D; Lacquaniti A; Coppolino G; Donato V; Fazio MR; Nicocia G; Buemi M
Kidney Blood Press Res; 2009; 32(2):91-8. PubMed ID: 19321980
[TBL] [Abstract][Full Text] [Related]
31. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
[TBL] [Abstract][Full Text] [Related]
32. Lack of relationship between urinary glycosaminoglycans and indices of tubular or glomerular renal damage. Urinary GAG are an unreliable nephrotoxicity index.
Bernard AM; Ouled A; Roels H; Lauwerys R; Vandeleene B; Lambert A
Nephron; 1988; 48(1):82-3. PubMed ID: 3340263
[No Abstract] [Full Text] [Related]
33. [Urinary proteins. c. Protein fractions].
Shiba K; Hiratsuka N
Rinsho Byori; 1998 Mar; Suppl 107():49-55. PubMed ID: 9569739
[No Abstract] [Full Text] [Related]
34. Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria.
Samarawickrama A; Cai M; Smith ER; Nambiar K; Sabin C; Fisher M; Gilleece Y; Holt SG
HIV Med; 2012 Oct; 13(9):526-32. PubMed ID: 22413854
[TBL] [Abstract][Full Text] [Related]
35. Tubular dysfunction in the early stage of diabetic nephropathy.
Tanaka A; Shima K; Fukuda M; Tahara Y; Yamamoto Y; Kumahara Y
Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397
[TBL] [Abstract][Full Text] [Related]
36. Nephelometry in the clinical assessment of glomerular proteinuria and tubular function in diabetic nephropathy.
Solerte SB; Severgnini S; Locatelli M; Cerutti N; Rondanelli M; Netti MA; Ferrari E; Fioravanti M
Clin Nephrol; 1997 Sep; 48(3):151-8. PubMed ID: 9342486
[TBL] [Abstract][Full Text] [Related]
37. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
[TBL] [Abstract][Full Text] [Related]
38. [Relationship of renal lesions with urinary protein excretion in patients with overt diabetic nephropathy].
Okada T; Matsumoto H; Nakao T; Nagaoka Y; Yamada C; Shino T; Yoshino M; Hidaka H; Han MG; Ootani M; Shimizu T
Nihon Jinzo Gakkai Shi; 1999 Aug; 41(5):475-85. PubMed ID: 10502941
[TBL] [Abstract][Full Text] [Related]
39. [Comparative evaluation of the selectivity of proteinuria in various types of diabetes mellitus].
Blagosklonnaia IaV; Mamedov R; Kozlov VV
Probl Endokrinol (Mosk); 1982; 28(5):6-9. PubMed ID: 6755443
[TBL] [Abstract][Full Text] [Related]
40. [Re-evaluation of proteinuria and qualitive methods for diagnosis of diabetic nephropathy].
Liu X; Fan J; Zhang W; Li K; Zhang X; Yang L; Sha Z; Xu G
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):88-90. PubMed ID: 12501624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
